Fulcrum Therapeutics (FULC) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.44
-0
0.43
0.87

Details

Expected EPS
-0.39625
Actual EPS
-0.35
Surprise EPS
0.05
Surprise Percent
+11.67%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.35 per share for Q4 2024.

0 Comments

Share your thoughts